We have already written about the thousands of Bard hernia mesh cases pending in Rhode Island state court moving swiftly towards bellwether trials. Not to be outdone, the federal Multidistrict Litigation (MDL) cases in the United States District Court for
Mass Torts Law Blog
The Mass Torts Law Blog, published by Stark & Stark, focuses on legal issues related to mass tort litigation involving defective medical devices, pharmaceuticals, and other product liability claims. The blog covers topics such as lawsuits and settlements for recalled implants like Exactech joint replacements, intrauterine devices like ParaGard, and medical devices including Philips Respironics CPAP machines. It also addresses vaccine injury compensation programs and related legal processes. The blog provides guidance on identifying potential claims, understanding litigation procedures including multidistrict litigation (MDL), and navigating complex mass tort cases.
Latest from Mass Torts Law Blog - Page 4
What is the Deal With TDF Drug and Truvada Lawsuits?
You have seen a lot of commercials and have probably been searching the internet for some straightforward explanations about TDF drug and Truvada lawsuits.
Very simply, TDF is short for tenofovir disoproxil fumarate. It is an HIV drug marketed…
Johnson & Johnson Slammed with $29.5M Verdict Over Baby Powder Suit
A California state jury found that pharmaceutical and manufacturing giant Johnson & Johnson’s talcum-based baby powder contained cancer-causing asbestos and caused a woman’s mesothelioma diagnosis. The jury awarded the woman a staggering $29.5 million.…
What Is the Deal With Hernia Mesh Lawsuits?
You have seen a lot of commercials and have probably been searching the internet for some straightforward explanations about hernia mesh lawsuits.
Very simply, a hernia is when a piece of internal tissue pushes through an opening in the…
Gout Treatment, Uloric, Found to Pose an Increased Risk of Death
The FDA has added a black box warning on uloric (febuxostat), finding that the gout treatment poses an increased risk of heart-related death compared to other gout treatment.
Febuxostat is an FDA-approved medication for the treatment of gout. Gout is…
Pradaxa (Dabigatran) Trials Continue Nationwide
In an October 2018, trial in West Virginia, a federal jury found that Boehringer Ingelheim Pharmaceuticals Inc. was not forthright about the risk of potential bleeding injuries with its drug, Pradaxa (Dabigatran). The jury awarded the plaintiff $250,000 for medical expenses…
Bard Hernia Mesh Litigation Update
Thousands of individuals have filed Bard mesh lawsuits against Bard and its corporate subsidiary, Davol. The Bard Hernia Mesh litigation, is currently pending in Rhode Island state court, as well as in federal court, in the Southern District of Ohio.…
Drugmakers React to Reinstatement of Incretin Mimetics Cases
As we have previously reported, safety concerns regarding incretin mimetics (such as Byetta, Januvia/Janumet and Victoza), led to more than a thousand lawsuits being filed across the country. Reports suggest that people taking the medications for the treatment…
The New Jersey Supreme Court’s Latest Decision Affecting Pharmaceutical Multicounty Litigation
On October 3, 2018, the New Jersey Supreme Court made its long-awaited decision in the Accutane Multicounty Litigation. Developed by the New Jersey-based pharmaceutical giant Hoffman-La Roche, Accutane is a prescription acne treatment that has been found to be…
FDA Bans Zhejiang Huahai Pharmaceutical Import as Valsartan Recall Continues
The U.S. Food and Drug Administration (FDA) has banned all imports of drugs and drug products from Zhejiang Huahai Pharmaceutical, which manufactured valsartan, a high blood pressure medication that had a possible carcinogenic impurity.
In July 2018, the FDA…